标题
RNA Interference as a Prospective Tool for the Control of Human Viral Infections
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-09-11
DOI
10.3389/fmicb.2018.02151
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhibition of dengue virus infection by small interfering RNAs that target highly conserved sequences in the NS4B or NS5 coding regions
- (2018) Paula M. Villegas et al. ARCHIVES OF VIROLOGY
- siRNA drug development against hepatitis B virus infection
- (2018) Robert Flisiak et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Development of subcutaneously administered RNAi therapeutic ARO-HBV for chronic hepatitis B virus infection
- (2018) C. Wooddell et al. JOURNAL OF HEPATOLOGY
- Post-exposure treatments for Ebola and Marburg virus infections
- (2018) Robert W. Cross et al. NATURE REVIEWS DRUG DISCOVERY
- Synthetic biology approach for plant protection using dsRNA
- (2018) Annette Niehl et al. PLANT BIOTECHNOLOGY JOURNAL
- Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives
- (2017) Tung-Hung Su et al. Gut and Liver
- Human Virus-Derived Small RNAs Can Confer Antiviral Immunity in Mammals
- (2017) Yang Qiu et al. IMMUNITY
- A phase 2a study evaluating the multi-dose activity of ARB-1467 in HBeAg positive and negative virally suppressed subjects with hepatitis B
- (2017) A. Streinu-Cercel et al. JOURNAL OF HEPATOLOGY
- RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
- (2017) Christine I. Wooddell et al. Science Translational Medicine
- RNA Interference Therapies for an HIV-1 Functional Cure
- (2017) Robert Scarborough et al. Viruses-Basel
- Advances in the delivery of RNA therapeutics: from concept to clinical reality
- (2017) James C. Kaczmarek et al. Genome Medicine
- A Simple and Cost-Effective Approach for In Vitro Production of Sliced siRNAs as Potent Triggers for RNAi
- (2017) Guihua Sun et al. Molecular Therapy-Nucleic Acids
- Questioning antiviral RNAi in mammals
- (2017) Benjamin R. tenOever Nature Microbiology
- Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population
- (2016) Geoff Symonds et al. AIDS PATIENT CARE AND STDS
- Inactivation of the type I interferon pathway reveals long double‐stranded RNA‐mediated RNA interference in mammalian cells
- (2016) Pierre V Maillard et al. EMBO JOURNAL
- ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients
- (2016) Jens Gottlieb et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools
- (2016) Henrik Paavilainen et al. JOURNAL OF MEDICAL VIROLOGY
- Current status and prospects of HIV treatment
- (2016) Tomas Cihlar et al. Current Opinion in Virology
- Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
- (2016) Jake Dunning et al. PLOS MEDICINE
- The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States
- (2015) Colleen S. Kraft et al. CLINICAL INFECTIOUS DISEASES
- Synthesis of 2′-Fluoro RNA by Syn5 RNA polymerase
- (2015) Bin Zhu et al. NUCLEIC ACIDS RESEARCH
- RNA interference approaches for treatment of HIV-1 infection
- (2015) Maggie L Bobbin et al. Genome Medicine
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- siPools: highly complex but accurately defined siRNA pools eliminate off-target effects
- (2014) Michael Hannus et al. NUCLEIC ACIDS RESEARCH
- Mechanistic evaluation of the transfection barriers involved in lipid-mediated gene delivery: Interplay between nanostructure and composition
- (2013) D. Pozzi et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Reciprocal Inhibition between Intracellular Antiviral Signaling and the RNAi Machinery in Mammalian Cells
- (2013) Gil Ju Seo et al. Cell Host & Microbe
- siRNA delivery: from basics to therapeutic applications
- (2013) Vladimir Torchilin Frontiers in Bioscience-Landmark
- Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection
- (2013) Christine I Wooddell et al. MOLECULAR THERAPY
- Production of highly potent recombinant siRNAs in Escherichia coli
- (2013) Linfeng Huang et al. Nature Protocols
- High-throughput purification of double-stranded RNA molecules using convective interaction media monolithic anion exchange columns
- (2012) Alesia Romanovskaya et al. JOURNAL OF CHROMATOGRAPHY A
- Enzymatically Produced Pools of Canonical and Dicer-Substrate siRNA Molecules Display Comparable Gene Silencing and Antiviral Activities against Herpes Simplex Virus
- (2012) Alesia Romanovskaya et al. PLoS One
- RNA interference and its potential applications to chronic HBV treatment: results of a Phase I safety and tolerability study
- (2011) Robert G Gish et al. ANTIVIRAL THERAPY
- The Double-Stranded RNA-Binding Protein PACT Functions as a Cellular Activator of RIG-I to Facilitate Innate Antiviral Response
- (2011) Kin-Hang Kok et al. Cell Host & Microbe
- Recent Advances in Understanding of the Immunological Off-Target Effects of siRNA
- (2011) Marta Olejniczak et al. CURRENT GENE THERAPY
- Ebolavirus Proteins Suppress the Effects of Small Interfering RNA by Direct Interaction with the Mammalian RNA Interference Pathway
- (2011) G. Fabozzi et al. JOURNAL OF VIROLOGY
- RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus
- (2010) Martin R. Zamora et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Breaking down the barriers: siRNA delivery and endosome escape
- (2010) M. Dominska et al. JOURNAL OF CELL SCIENCE
- Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
- (2010) Thomas W Geisbert et al. LANCET
- A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
- (2010) J. DeVincenzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA-Based Gene Therapy for HIV with Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
- (2010) D. L. DiGiusto et al. Science Translational Medicine
- RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy
- (2009) R. Alvarez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of coxsackievirus B3 and related enteroviruses by antiviral short interfering RNA pools produced using 6 RNA-dependent RNA polymerase
- (2009) M. Nygardas et al. JOURNAL OF GENERAL VIROLOGY
- Lipid-based nanotherapeutics for siRNA delivery
- (2009) A. Schroeder et al. JOURNAL OF INTERNAL MEDICINE
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- The biology of CCR5 and CXCR4
- (2009) Ghalib Alkhatib Current Opinion in HIV and AIDS
- Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)
- (2008) J DEVINCENZO et al. ANTIVIRAL RESEARCH
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
- (2008) Priti Kumar et al. CELL
- Origins and evolution of eukaryotic RNA interference
- (2008) S SHABALINA et al. TRENDS IN ECOLOGY & EVOLUTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started